Search
Results: 7
New immunological potential markers for triple negative breast cancer
Paolo Marchetti, Alexey Antonov, Lucia Anemona, Chaitania Vangapandou, Manuela Montanaro, Andrea Botticelli, Alessandro Mauriello, Gerry Melino, M Valeria Catani
Mar 23, 2021
Breast cancer (BC) is the second leading cause of cancer death in women worldwide, and settings of specific prognostic factors and efficacious therapies are made difficult by phenotypic heterogeneity of BC subtypes. Therefore...
New immunological potential markers for triple negative breast cancer
Paolo Marchetti, Alexey Antonov, Lucia Anemona, Chaitania Vangapandou, Manuela Montanaro, Andrea Botticelli, Alessandro Mauriello, Gerry Melino, M Valeria Catani
Mar 28, 2022
Breast cancer (BC) is the second leading cause of cancer death in women worldwide, and settings of specific prognostic factors and efficacious therapies are made difficult by phenotypic heterogeneity of BC subtypes. Therefore...
New immunological potential markers for triple negative breast cancer
Paolo Marchetti, Alexey Antonov, Lucia Anemona, Chaitania Vangapandou, Manuela Montanaro, Andrea Botticelli, Alessandro Mauriello, Gerry Melino, M. Valeria Catani
Mar 10, 2021
Abstract: Breast cancer (BC) is the second leading cause of cancer death in women worldwide, and settings of specific prognostic factors and efficacious therapies are made difficult by phenotypic heterogeneity of BC subtypes....
Cancer Treatment in the Genomic Era.
Gary J Doherty, Michele Petruzzelli, Emma Beddowes, Saif S Ahmad, Carlos Caldas, Richard J Gilbertson
Oct 16, 2019
The complexity of human cancer underlies its devastating clinical consequences. Drugs designed to target the genetic alterations that drive cancer have improved the outcome for many patients, but not the majority of them. Here...
Lesion-specific 3D-printed moulds for image-guided tissue multi-sampling of ovarian tumours
Maria Delgado-Ortet, Marika Av Reinius, Cathal McCague, Vlad Bura, Ramona Woitek, Leonardo Rundo, Andrew B Gill, Marcel Gehrung, Stephan Ursprung, Helen Bolton, Krishnayan Haldar, Pubudu Pathiraja, James D Brenton, Mireia Crispin-Ortuzar, Mercedes Jimenez-Linan, Lorena Escudero Sanchez, Evis Sala
Feb 27, 2023
Predictive Biomarkers of Immune Checkpoint Inhibition in Gastroesophageal Cancers.
Immune checkpoint inhibition has transformed cancer treatment. For gastroesophageal cancer, this class of drugs have demonstrated durable responses and survival benefit in a subgroup of patients, resulting in regulatory...